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Inverse Agonist-Like Action of Cadmium on G-Protein-Gated Inward-
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The gate at the pore-forming domain of potassium channels is allosterically
controlled by a stimulus-sensing domain. Using Cd2þ as a probe, we examined
the structural elements responsible for gating in an inward-rectifier Kþ chan-
nel. We generated a cysteine-free mouse Kir3.2 mutant (C1234) in which the
four cysteine residues that are potentially exposed to the cytoplasm were re-
placed. These residues were as follows: Cys65 in the N-terminal portion of
the cytoplasmic domain, Cys190 in the second transmembrane helix, and
Cys221 and Cys321 in the bC and bI strands, respectively, of the C-terminal
portion of the cytoplasmic domain. One of four endogenous cysteines of
Kir3.2 (Cys65) the cysteines of which potentially face the cytoplasm contrib-
utes to a high-affinity site for inhibition by internal Cd2þ. Crystal structure
of its cytoplasmic domain in complex with Cd2þ reveals that octahedral coor-
dination geometry supports the high-affinity binding at Cys65. This mode of
action causes the tethering of Cys65 on the N-terminus to His233 on the CD
loop in the stimulus-sensing domain. We previously reported that the interac-
tion of these structural elements via an ionic bond between His69 and
Asp228 maintained the channel in a closed state by lowering the sensitivity
to phosphatidylinositol-4,5-bisphosphate. Therefore, the mode of binding of
Cd2þ reveals that ‘‘inverse agonist’’-like action is a mechanism underlying
the inhibition of Kir3.2 by Cd2þ and also that the N-terminus and CD loop
are the structural elements participate in gating.
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G protein-activated Kþ channels (GIRK; Kir3) channels are prototypical effec-
tors of Gbg. Inhibitory neurotransmitters evoke Kþ currents via GIRK, but
GIRKs also have basal Gbg-dependent activity. We proposed that basal and
evoked activities are interdependently regulated, but the mechanism remains
unknown. We show that heterologous expression of neuronal GIRK1/2 chan-
nels is accompanied by a large increase in surface expression of Gbg but not
Gai. Calibrated protein expression within a range of less than one to several
tens of molecules/mm2 and mathematical modeling suggest that each GIRK1/
2 ‘‘drags’’ to plasma membrane 3 to 4 molecules of Gbg but less than 2 mol-
ecules of Gai. The effector-dependent, non-stoichiometric changes in Gbg and
Gai levels quantitatively and qualitatively account for the reciprocal changes in
basal and evoked activities upon incremental expression of GIRK1/2. A similar
reciprocal relation between basal and evoked currents is found in hippocampal
neurons, suggesting that preferential association of GIRK with Gbg over Gai
plays a role in controlling excitability.
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Andersen’s syndrome (AS) is a rare and dominant pathology linked to the in-
ward rectifying potassium channel Kir 2.1. Patients exhibit a triad of symp-
toms: periodic paralysis, cardiac dysrhythmia and bone malformations. We
have made progress in understanding the contribution of the Kir2.1 channel
in skeletal and cardiac muscle dysfunctions but we are still missing the link
to bone morphogenesis.
We isolated myoblast precursors from muscle biopsies from three healthy in-
dividuals and three typical AS patients that exhibit dysmorphic features. Myo-
blast cultures underwent either myogenic or osteogenic differentiation using
the appropriate medium. We used Alizarin, Von Kossa, and alkaline phospha-
tase staining techniques to monitor osteobalst differentiation mineralization.
While myogenic differentiation was not affected, we found that only cellsfrom control patients underwent osteoblastic differentiation as they were pos-
itively stained.
To further demonstrate the role of the Kir2.1 channels in the osteogenic differ-
entiation of myoblasts, we blocked Kir2.1 channel activity in control patient’s
cells either by treatment with 0.5 mM BaCl2 or by inhibiting its expression by
overexpression of a dominant negative form of the channel. In both cases, cells
lost the capacity to mineralize their extracellular matrix.
We also carried out rescue experiments on AS patient’s cells by infection with
adenovirus carrying the wild type form of the channel. These cells become able
to express alkaline phosphatase and mineralize their extracellular matrix. Thus,
our study strongly suggests that the potassium channel Kir 2.1 is required for
the differentiation of myoblast precursors into osteoblast in vitro. Further
work will shed light on the molecular mechanisms leading to bone dysmorphol-
ogy associated with Kir2.1 dysfunction.
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Introduction: Caveolin-3 (Cav3) is a cardiac specific structural and anchoring
protein necessary for the formation of caveolae. We have previously reported
that mutations on Cav3 that cause LQTS-9 (F97C, T78M, A85T, S141R) mod-
ulate the current through inward rectifier potassium channel, Kir2.1. This pro-
ject investigates the mechanism by which Cav3 F97C affects Kir2.1 channel
biophysical properties.
Methods: On cell western blotting technique andstandard voltage clamp tech-
niques were used to elucidate the mechanism.
Results: An extracellular hemagglutinin (HA) tagged Kir2.1 was used in de-
tecting cell surface expression of Kir2.1. HEK293 cells were co-transfected
with Kir2.1-HA and Cav3-WT or Cav3-F97C constructs. Cells were fixed 22
hours after transfection with 4% paraformaldehyde. LI-COR odyssey system
was used to perform the on cell western. On cell western experiments suggest
that Cav3 F97C sig-
nificantly decreased
the cell surface ex-
pression of Kir2.1
by ~50%, shown in
the figure below.
Conclusion: Our
experiments suggest
that one of the mech-
anism bywhich Cav3
F97C affects Kir2.1
current density is by
decreasing the cell
surface expression
of Kir2.1 channels.
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Cholesterol is known to play a major role in regulation of variety of ion chan-
nels but the mechanisms underlying cholesterol sensitivity of ion channels are
still poorly understood. In this study, we address the key question of whether
cholesterol-induced regulation of ion channel function can be attributed to di-
rect binding of the lipid to the channel protein and our observations provide the
first direct evidence that cholesterol binds to an ion channel. Specifically, we
show that cholesterol binds to a prokaryotic Kir channel, KirBac1.1 in a satura-
ble way and that there is clear competition between radioactive and non-
radioactive cholesterol for the binding site. There is no competition, however,
between cholesterol and 5-Androsten 3b-17 b-diol, a sterol that we showed pre-
viously to have no effect on KirBac1.1 function. Furthermore, inhibition of
cholesterol-KirBac1.1 binding by trifluoperazine, known to inhibit cholesterol
binding to other proteins results in full recovery of the channel activity. Taken
together, results from this study indicate that cholesterol-induced suppression
of KirBac1.1 activity is mediated by direct interaction between cholesterol
and the channel protein.
